Author | Thomas J. Kipps, MD


How Do Targeted Therapies Change the Management of Indolent Lymphomas?

September 15, 2016

ByMichael Y. Choi, MD|Thomas J. Kipps, MD

Prior to the advent of targeted therapies, there were few options other than chemotherapy for the treatment of patients with indolent B-cell lymphomas or chronic lymphocytic leukemia.